A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19

…, YK Cheung, V Gupta, E João… - The Journal of …, 2021 - Am Soc Clin Investig
BACKGROUND Although convalescent plasma has been widely used to treat severe
coronavirus disease 2019 (COVID-19), data from randomized controlled trials that support its …

Understanding the relation between Zika virus infection during pregnancy and adverse fetal, infant and child outcomes: a protocol for a systematic review and …

…, Z Lan, AD LaBeaud, M Koopmans, C Kim, E João… - BMJ open, 2019 - bmjopen.bmj.com
Introduction Zika virus (ZIKV) infection during pregnancy is a known cause of microcephaly
and other congenital and developmental anomalies. In the absence of a ZIKV vaccine or …

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir …

…, V Korutaro, H Cassim, BT Mmbaga, E João… - The Lancet, 2021 - thelancet.com
Background Antiretroviral therapy (ART) during pregnancy is important for both maternal
health and prevention of perinatal HIV-1 transmission; however adequate data on the safety …

In-hospital mortality and severe outcomes after hospital discharge due to COVID-19: A prospective multicenter study from Brazil

…, K Geraldo, L Freitas, VV Pacheco, EC João… - The Lancet Regional …, 2022 - thelancet.com
Background We evaluated in-hospital mortality and outcomes incidence after hospital discharge
due to COVID-19 in a Brazilian multicenter cohort. Methods This prospective multicenter …

Three postpartum antiretroviral regimens to prevent intrapartum HIV infection

…, VG Veloso, YJ Bryson, EC Joao… - … england Journal of …, 2012 - Mass Medical Soc
Background The safety and efficacy of adding antiretroviral drugs to standard zidovudine
prophylaxis in infants of mothers with human immunodeficiency virus (HIV) infection who did …

Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial

EC João, RL Morrison, DE Shapiro, N Chakhtoura… - The Lancet …, 2020 - thelancet.com
Background Although antiretroviral regimens containing integrase inhibitors rapidly suppress
HIV viral load in non-pregnant adults, few published data from randomised controlled trials …

Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase …

…, CB Hofe, TF de Abreu, LM Pestanha, E João… - The Lancet …, 2023 - thelancet.com
Background Drugs taken during pregnancy can affect maternal and child health outcomes,
but few studies have compared the safety and virological efficacy of different antiretroviral …

Mycobacteremia in patients with the acquired immunodeficiency syndrome

…, FCO Fandinho, VG Veloso, EC João… - Archives of internal …, 1997 - jamanetwork.com
Background: Bacillemia is a key event in the pathogenesis of tuberculosis. Although current
evidence indicates thatMycobacterium tuberculosisbacteremia is rare in patients …

Chlamydia and gonorrhea in HIV-infected pregnant women and infant HIV transmission

…, VG Veloso, JH Pilotto, E Joao… - Sexually transmitted …, 2015 - journals.lww.com
Background Sexually transmitted infections (STIs) such as Chlamydia trachomatis (CT) and
Neisseria gonorrhoeae (NG) can lead to adverse pregnancy and neonatal outcomes. The …

Syphilis in HIV-infected mothers and infants: results from the NICHD/HPTN 040 study

…, HD Watts, M Camarca, G Soares, E Joao… - The Pediatric …, 2015 - journals.lww.com
Background: Untreated syphilis during pregnancy is associated with spontaneous abortion,
stillbirth, prematurity and infant mortality. Syphilis may facilitate HIV transmission, which is …